If you need an update on this week’s Pharma industry news and reports, here is a brief round-up:
Cell-Based Assays Market by Product, Application, End-user – Global Forecast to 2018
This Markets & Markets report studies the global cell-based assays market over the forecast period of 2013 to 2018. The opportunities for the growth of this market include developments in emerging markets such as Asia, introduction of technologically advanced products, and increase need of toxicity screening. However, factors such as intellectual property rights are restricting innovation in the market and hence hindering growth. Click here to read the report summary and/or access the full report.
Mass Spectrometry Market – Global Trends & Forecast to 2018
The global mass spectrometry market is currently witnessing a healthy growth due to the increasing demand for hyphenated and tandem techniques that involve mass spectroscopy. The technology finds its applications across multiple sectors, including the government research, energy, utilities, pharmaceuticals, diagnostics and environmental, food and beverage, security and defense, and industrial chemicals fields. Click here to read the report summary and/or access the full report.
Specialty Enzymes Market by Source, Type, Application & Geography – Global Trends & Forecasts to 2018
A new report from Markets and Markets defines and segments the specialty enzymes market with an analysis and forecast of the global value for specialty enzymes. North America is the largest market for the demand of Specialty enzymes with U.S commanding a major share of the market. Click here to read the report summary and/or access the full report.
Protein Expression Market by Products, Application, Expression Systems & by End User – Global Forecast to 2018
Protein expression forms an integral part of proteomic research as many commercially important proteins are produced downstream of protein expression. The protein expression market is expected to be driven by a number of factors. In the pharmaceutical sector, decline in the productivity of R&D and the sales drop expected by the upcoming patent cliff has resulted in intense research activities. Furthermore, the rise of the biologics market will increase research related to it, while the growth of the proteomics market will boost the protein expression market to a large extent. Click here to read the report summary and/or access the full report.
Choosing The Right CMO For HPAPI Manufacturing
Over the past few years a steady stream of contract manufacturing organizations (CMO) have added high potency active pharmaceutical ingredient (HPAPI) production capacity. The expansions give biopharma executives charged with selecting HPAPI production partners an unprecedented number of options. Click here to read “Choosing the Right CMO for HPAPI Manufacturing”, authored by Brian Haney, Ph.D., Director of Manufacturing, Albany Molecular Research Inc. (AMRI).
AstraZeneca’s Lab Talk: Scientific Discoveries Improve Understanding of Tourette’s Disorder
As a project leader in AstraZeneca’s Neuroscience iMed, Stephen Zicha, Ph.D., Project Director, is fascinated by scientific discoveries that help to aid in the understanding of pathogenic mechanisms that cause poorly understood neurodevelopmental disorders, such as Tourette’s disorder. He explains that recent findings, such as a mutation affecting histamine synthesis, may lead to the development of new treatments that meaningfully improve patients’ lives. Read Dr. Zicha’s full blog post here.
Derek Lowe’s In the Pipeline: “Artificial Base Pairs in Living Cells”
A recent blog post at In the Pipeline examines how synthetic biology seems to have taken another big step. According to the post, many labs over the years have tried out expanding the genetic code in various ways, but all these run in various in vitro systems. Now the first organism has been engineered with a working unnatural base pair, according to a recent paper by the Romesburg group at Scripps in Nature. Read Derek’s full blog post here.
Rob Wright’s Blog: The U.S. Pharmaceutical Industry — Between A Hard Rock Of Hope And A Heartbreak
Life Science Leader magazine’s Chief Editor Rob Wright recaps a portion of the 2014 PhRMA annual meeting in Washington, D.C., which includes highlighting thoughts and experiences from Suleika Jaouad, an Emmy Award-winning New York Times Well columnist, health advocate and cancer survivor. In the blog, Rob also recalls his own experiences with Pharma and sheds light on the societal contributions of the pharmaceutical and biotech industries. Read Rob’s full blog post here.